Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine Infusion for Oxygenation in COPD Patients During One Lung Ventilation
NCT02962999Phase 4Completed
- Sponsor
- Cukurova University
- Start
- Jan 2017
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ketamine in chronic obstructive pulmonary disease (COPD), sponsored by Cukurova University. Started Jan 2017; status: completed.
02
Drugs
ketamine
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02962999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02962999.